Cargando…
Should cancer patients receiving ICIs received COVID-19 vaccination?
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050498/ http://dx.doi.org/10.1007/s40278-021-94098-4 |
Ejemplares similares
-
Immunocompromised patients in the USA and UK should receive third dose of COVID-19 vaccine
por: Furlow, Bryant
Publicado: (2021) -
Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy
por: Moastafa, Tarek M., et al.
Publicado: (2014) -
Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration
por: Guan, Rui, et al.
Publicado: (2021) -
The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine
por: Harshman, L C, et al.
Publicado: (2013) -
Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?
por: Rajan, S, et al.
Publicado: (2013)